As a global leader in the life sciences, diagnostics and applied chemistry markets, Agilent Technologies is focused on research and development of products in the fields of communications and life sciences, production, sales and technical services. However, in recent years, instrument Driven by the wave of mergers and acquisitions in the industry, Agilent also began to expand the strong layout of its operations by mergers and acquisitions. Xiao Bian summarized the major M&A acquisitions that Agilent could count in the first half of this year and hoped to help people understand Agilent's Acquisition trend.
Agilent Acquires Luxcel Biosciences Expands Cell Analysis Product Family
On January 10, 2018, Agilent Technologies announced the acquisition of Luxcel Biosciences Inc. (Luxcel) in Cork, Ireland. The company develops in vitro cell detection kits based on real-time fluorescence microplate readers. This acquisition is new to Agilent. The easy-to-use test kit compatible with industry-standard microplate readers extends the Agilent cell analysis product line. Luxcel was founded in 2002 by Richard Fernandes and Dmitri Papkovsky, is the spin-off company of the University of Cork and the Irish Enterprise Bureau. One of the High Potential Start-Up projects, with 12 employees, is headquartered in Cork, Ireland. The Luxcel team will stay in Cork and set up a dedicated sensor chemistry in Agilent's Cell Analysis Division. Biometric Solutions Group. The acquisition did not disclose the financial terms of the transaction.
Agilent's $250 Million Acquisition of Advanced Analytical Technologies
Agilent Technologies Inc. announced today that it has signed a definitive agreement to acquire a private company, Advanced Analytical Technologies, Inc. (AATI), a supplier of capillary electrophoresis solutions that provides comprehensive automated analysis of various molecules. The acquisition was sold for $250 million in cash. The acquisition will strengthen Agilent's professional and technical capabilities to provide customers with a more comprehensive portfolio of solutions. Mr. Patrick Kaltenbach, Agilent's senior vice president and president of the Life Sciences and Applications Market Group, said: 'This acquisition proves once again that Agilent is creating higher value for customers and shareholders through the effective use of investment. AATI's products can complement our existing solution portfolio, further enhance our strength and give us the opportunity to realize more. Fast business growth. '
Agilent invests $105 million in reacquisition
In April 2018, Agilent Technologies announced the signing of a definitive agreement to purchase the remaining 52% of Lasergen for $105 million. Lasergen is an emerging biotechnology company focused on the development of DNA innovations. Agilent was acquired two years ago. Its 48% stake. Jacob Thaysen, president of the Agilent Diagnostics and Genomics Group, said: 'Building next-generation sequencing workflows for clinical applications is a critical component of Agilent's diagnostic strategy to combat cancer and constitutional diseases. We are committed to providing patient-centered decisions for clinical decision making. , And operational information, ensure the customer experience of all diagnostic modes, making it a key differentiator in the future.
Agilent Acquires Genohm to Strengthen Laboratory Informatics Construction
Agilent Technologies Inc. announced today that it has signed a definitive agreement to acquire a privately held Genohm company. The company is a developer of highly differentiated, on-premise and cloud computing software solutions for laboratory management. Agilent vice president and software John Sadler, general manager of the Informatics Division, said: “The team and technology of Genohm have left a deep impression on us. The modern architecture of SLIMS is in perfect harmony with the value of Agilent OpenLab products. By diversifying the technology with us The instrument portfolio is integrated and we are in a unique position to support and strengthen modern laboratory operations - truly helping our customers do more with their data.
What is the intention of Agilent to announce the acquisition of a distributor's assets?
On May 22, 2018, Agilent announced that Agilent and Young In Scientific Co. Ltd. have signed a definitive agreement to acquire related businesses. YI Scientific is Korea's leading distributor of analytical and scientific instruments, and Agilent's long-term cooperation in the distribution of instruments and services. According to Lon Justice, vice president of Agilent Labs Solutions Sales and Marketing, “YI Scientific has established a strong sales channel for Agilent over the years. Cooperation with channel partners has established Agilent’s requirements for Korea’s growing analytical market. Solid foundation. ' After the acquisition is completed, YI Scientific and its subsidiaries have more than 100 employees expected to join Agilent Technologies Korea Limited.
It goes without saying that with the continuous influx of large amounts of capital, it will inevitably exacerbate the competition in the instrument market. Through the acquisition strategy, some companies with absolute leading edge in the subdivided area will stand out in the new competitive environment. In the future, more companies will use this Means to inject strong driving force for brand development, who will be the biggest winner in the market, may wish to wait and see! After several acquisitions in the first half, Agilent will be dead or will set off a new round of mergers and acquisitions frenzy? We will wait and see.
